System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Norbert Suttorp is an expert in Pulmonology at Charité - University Medicine Berlin (Germany). As of October 2026, ScienceLeadR ranks Norbert Suttorp in the top 1% of experts worldwide for Community-Acquired Pneumonia and Pneumonia. Norbert Suttorp has authored 358 publications, the most recent in 2026, and is an investigator in 3 clinical trials, 1 of them ongoing. SLR score: 1,063 (community average: 125). How the SLR is computed.

LeadR Profile

Norbert Suttorp Charité - University Medicine Berlin Germany
1 063 ScienceLeadR Reputation 1063

Unlock

Register Login
Network Map

Pulmonology

Subspecialties: Infectiology - Biochemistry - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2006 - 2026
Source: PubMed

Charité - University Medicine Berlin

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 358

Citations

Citations: 23 459 1st author: 3 Last author: 39 Unique author: 4

Main journals

Eur Respir J 14
Infection 13
PLoS One 12
J Immunol 11
Pneumologie 11

Best Journals

Cell 5
Lancet Respir Med 2
Nat Biotechnol 2

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Community-Acquired Pneumonia: Disease Course Prediction With a 5-Gene Signature.
PMID 42548383 — genes, mortality, pneumonia, prospective studies, gene expression, community-acquired pneumonia		CHEST Pulm20260
Admission Eosinophil Count Is Associated with Hospital Resource Utilization in Community-Acquired Pneumonia: A Prospective Multicenter Study.
PMID 41933608 — cells, glucocorticoids, eosinophils, biomarkers, pneumonia, intensive care units, ventilation, community-acquired pneumonia		Chest20260
Blood eosinopenia (≤30/µL) as an early predictor of respiratory failure in community-acquired pneumonia: A prospective multicentre study.
PMID 41511276 — blood, eosinophils, biomarkers, pneumonia, ventilation, community-acquired pneumonia		Pulmonology20260
Community-acquired pneumonia in diabetic patients is characterised by a distinct pathogen spectrum and enhanced inflammation: results from CAPNETZ, a prospective observational cohort study.
PMID 41077620 — diabetes mellitus, cohort studies, pneumonia, history, infections, community-acquired pneumonia		Infection20250
[Healthcare landscape in internal medicine in Germany: A trend analysis over 10 years for the German Society of Internal Medicine (DGIM)].
PMID 40139196 — internal medicine, medical staff, beds, outpatients		Dtsch Med Wochenschr20250

Clinical Studies 3

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

N/A 2
Phase 3 1

By status:

Completed 2
Recruiting 1

By type:

Observational 2
Interventional 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 0
multicentricup10 3

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Study of Progression of Community Acquired Pneumonia in the Hospital in Patients With More Severe Preexisting Diseases and Immunosuppression
NCT05688774 — shock, septic, disease progression, preexisting condition coverage, pneumonia, sepsis, complement system proteins, therapeutics, immunosuppression therapy, community-acquired pneumonia		N/ARecruiting2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS